BMW has issued a cautious outlook for 2026, warning that group pre-tax earnings will fall further and vehicle deliveries will remain flat as rising trade barriers continue to squeeze its core automotive business. The German luxury automaker cited escalating tariff headwinds as a key drag on profitability, projecting that higher import duties will shave approximately 1.25 percentage points off its automotive EBIT margin this year.
The company expects its automotive segment EBIT margin to land between 4% and 6% in 2026, stepping down from the 5.3% recorded in 2025. Group earnings before tax, which already dropped 6.7% last year to 10.2 billion euros, are projected to decline by an additional 5% to nearly 10% over the course of this year.
Global delivery volumes are expected to hold roughly steady compared to 2025, a year marked by a significant sales slump in China, one of BMW's most critical growth markets. Weak Chinese consumer demand has remained a persistent challenge for European premium automakers navigating an increasingly competitive local electric vehicle landscape.
On the U.S. front, BMW's substantial manufacturing footprint has provided some protection against American import tariffs. Its flagship production facility in Spartanburg, South Carolina, the largest BMW plant in the world by output, allows the brand to supply a portion of the American market with domestically built vehicles. However, this advantage is partially offset by European Union tariffs applied to electric Mini models manufactured in China.
Despite these headwinds, BMW remains focused on managing costs and expanding its electric vehicle lineup to strengthen its competitive position in key global markets. The results reflect broader pressures facing the European auto industry as it adapts to shifting trade policies, softening demand in Asia, and the ongoing transition toward electrification.


Applied Materials Forecasts Strong Q3 Revenue as AI Chip Demand Accelerates
Google, Blackstone Launch $5B AI Cloud Venture to Challenge Nvidia and CoreWeave
Amazon Faces Class-Action Lawsuit Over Trump Tariff Price Hikes
Anthropic to Brief Financial Stability Board on AI-Driven Cyber Risks
Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme
FTC Antitrust Probe Targets Arm Holdings Over Chip Licensing Practices
Sonova Beats Profit Forecasts Despite Cochlear Implant Weakness
CXMT Forecasts Record Revenue Growth as Global DRAM Prices Surge
Thyssenkrupp to Shut Down Indiana Automotive Plant by March 2026
Analog Devices Nears $1.5B Acquisition of AI Chip Firm Empower Semiconductor
Elliott Targets Bio-Rad as Shares Continue to Struggle
Samsung Faces Major Strike Threat as Union Restarts Pay Talks
US-China Trade Talks Sideline Chip Export Controls as Nvidia China Sales Draw Attention
TrumpRx Expands Discount Drug Access With 600 Generic Medications
SpaceX Shareholders Approve 5-for-1 Stock Split Ahead of Potential IPO 



